

%201.webp)


%201.webp)




LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。



%201.webp)


%201.webp)




序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

Pharmaceutical products in Lebanon are regulated by the Ministry of Public Health (MOPH). Lebanon has introduced a national pharmaceutical verification and traceability initiative designed to improve supply chain transparency and combat counterfeit medicines.
The country operates a Medicine Barcode System that requires pharmaceutical products to carry GS1 compliant DataMatrix barcodes. The barcode enables verification of medicines through the Ministry of Public Health digital verification platform.
The Lebanese traceability initiative allows healthcare professionals, pharmacists, and regulators to verify medicines by scanning the barcode and confirming product authenticity through the national system. The framework supports identification of medicines throughout the distribution process and helps detect counterfeit or illegally imported products.
Serialization requirements apply primarily to human medicines registered and distributed within the Lebanese pharmaceutical market.
Medicinal products distributed in Lebanon must include a 2D DataMatrix barcode on the secondary packaging.
The barcode must follow GS1 standards and typically contains the following elements:
These elements allow each medicine package to be uniquely identified and verified through the national verification system.
The barcode must be clearly printed on the packaging and must correspond to the human readable product information displayed on the label.
2017–2018
The Ministry of Public Health began introducing initiatives to strengthen pharmaceutical supply chain monitoring and combat counterfeit medicines.
2019 onward
The national medicine barcode verification system was introduced to enable authentication and tracking of medicines using GS1 compliant DataMatrix barcodes.
Current Status
Serialized DataMatrix identification and barcode verification are used to support pharmaceutical supply chain monitoring in Lebanon.
Supply chain participants must ensure that medicines can be verified through the national barcode verification system.
Lebanon operates a centralized medicine verification platform managed by the Ministry of Public Health.
The system allows pharmaceutical supply chain participants to verify medicines by scanning the barcode and confirming product authenticity through the Ministry’s digital services.
Participants interacting with the system include:
The platform supports verification of medicines and monitoring of pharmaceutical distribution within the country.
Lebanon’s traceability framework focuses primarily on unit level serialization using DataMatrix barcodes.
Aggregation at case or pallet level is not explicitly mandated in publicly available regulatory guidance. Pharmaceutical companies may implement aggregation internally to support logistics and warehouse management operations.
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.